Bogart Wealth’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
Bogart Wealth's KYMR Position: Q3 2026 in Review
Bogart Wealth opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 4 shares worth $447. The stake represents ﹤0.01% of the portfolio and ranks #1856 among its holdings. This is a return to the name: Bogart Wealth previously reported a position in KYMR as recently as Q1 2026.
Bogart Wealth first reported a position in KYMR in Q1 2026 and has held it in 2 quarters since. 299 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- Bogart Wealth held 4 shares of Kymera Therapeutics worth $447 as of Q3 2026.
- Kymera Therapeutics was a new Bogart Wealth position in Q3 2026.
- Kymera Therapeutics made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1856 holding.
- Bogart Wealth first reported a position in Kymera Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 299 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.